Respiratorius AB (publ)
556552-2652ActiveDeveloping novel drugs to treat aggressive lymphoma cancers.
Biotechnology/Pharmaceutical Companyrespiratorius.com
Översikt
- Okänt
- Anställda
- Okänt
- Omsättning
- 1998
- Grundat
Nyckelbeslutsfattare
Johan Drott
CEO
@respiratorius.com+46709XXXXXX
Karin Wehlin
Chairman of the Board
@respiratorius.com
Kristina Drott
Board member
@respiratorius.com
Mia Lundblad
Board member
@respiratorius.com
Beskrivning
Respiratorius AB (publ) is a specialized biotechnology company focused on developing novel drug candidates for treating aggressive cancers. Their primary mission is to reduce the global burden of aggressive lymphoma, particularly Diffuse large B-cell lymphoma (DLBCL). The company bases its drug cand...
BIOINVENT INTERNATIONAL AB